indicated that in acute myeloid leukemia, PTGDR2 inhibited the KRAS-mediated MAPK and PI 3 K/AKT/mTOR signaling pathways, thereby promoting apoptosis of LICs (26). The gene discussed is MTOR; the disease is acute myeloid leukemia.